Treatment.com special warrants to convert Dec. 27
Dr. Essam Hamza reports
Treatment.com AI Inc. has filed a prospectus supplement dated Dec. 20, 2024, to its short form base shelf prospectus dated June 24, 2024, to qualify the distribution of securities underlying 2,138,766 special warrants issued by the company on Oct. 25, 2024.
The prospectus supplement qualifies the distribution of 2,138,766 common shares and 1,069,383 common share purchase warrants comprising the units of the company issuable on the exercise or deemed exercise of the special warrants in the provinces of British Columbia, Alberta, Manitoba and Ontario. Each warrant entitles the holder thereof to acquire one common share at an exercise price of $1 until 5 p.m. Pacific Time for a period of 24 months.
The special warrants will be deemed to be converted into common shares and warrants on Dec. 27, 2024. No action is required on the part of any holder of special warrants to convert their special warrants into underlying securities.
The qualification rights of holders of special warrants are further described in the prospectus supplement and the shelf prospectus, which can be found under the company’s profile on SEDAR+.
Access to the shelf prospectus, the prospectus supplement and any amendment to the documents is provided in accordance with securities legislation relating to procedures for providing access to a shelf prospectus supplement, a base shelf prospectus and any amendment. The shelf prospectus and the prospectus supplement are accessible on SEDAR+. An electronic or paper copy of the prospectus supplement, the corresponding shelf prospectus and any amendment to the documents may be obtained, without charge, from the company by e-mail at info@treatment.com and by providing the contact with an e-mail address or address, as applicable.
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the health care sector and impact current inefficiencies and challenges. With the input of hundreds of health care professionals globally, Treatment.com AI has built a comprehensive, personalized health care AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all health care professionals as well as providing recommended tests (physical and lab), X-rays and billing codes. The GLM helps health care professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. Treatment.com AI’s GLM platform, through supporting health care professionals, allows for the inclusion of disenfranchised communities.
We seek Safe Harbor.